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Background: Policy makers and regulators are constantly required to make decisions despite the existence of
substantial uncertainty regarding the outcomes of their proposed decisions. Understanding stakeholder views is an
essential part of addressing this uncertainty, which provides insight into the possible social reactions and tolerance
of unpredictable risks. In the field of nanotechnology, large uncertainties exist regarding the real and perceived risks
this technology may have on society. Better evidence is needed to confront this issue.
Methods: We undertook a computer assisted telephone interviewing (CATI) survey of the Australian public and a
parallel survey of those involved in nanotechnology from the academic, business and government sectors. Analysis
included comparisons of proportions and logistic regression techniques. We explored perceptions of nanotechnology
risks both to health and in a range of products. We examined views on four trust actors.
Results: The general public’s perception of risk was significantly higher than that expressed by other stakeholders. The
public bestows less trust in certain trust actors than do academics or government officers, giving its greatest trust to
scientists. Higher levels of public trust were generally associated with lower perceptions of risk. Nanotechnology in food
and cosmetics/sunscreens were considered riskier applications irrespective of stakeholder, while familiarity with
nanotechnology was associated with a reduced risk perception.
Conclusions: Policy makers should consider the disparities in risk and trust perceptions between the public and
influential stakeholders, placing greater emphasis on risk communication and the uncertainties of risk assessment in
these areas of higher concern. Scientists being the highest trusted group are well placed to communicate the risks of
nanotechnologies to the public.
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Policy makers and regulators are constantly required to
make decisions despite the existence of substantial un-
certainty regarding the outcomes of their proposed deci-
sions. Over the past two decades the engagement of the
public has been increasingly encouraged as a way to im-
prove these decision outcomes in areas of environmental* Correspondence: acap1921@uni.sydney.edu.au
1Menzies Centre for Health Policy, School of Public Health, University of
Sydney, Sydney, Australia
2Environmental Health Branch, Health Protection NSW, 73 Miller St, North
Sydney, Sydney, Australia
Full list of author information is available at the end of the article
© 2015 Capon et al.; licensee BioMed Central.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.risk such as air pollution [1], genetically modified organ-
isms [2], climate change [3] and nanotechnology [4-11].
Nanotechnology is a collective term for a range of
technologies, techniques and processes that involve the
manipulation of matter at the nanoscale – a size range
from approximately 1 nanometre to 100 nanometres
[12]. While consumer products developed with nano-
technology have the potential to revolutionise our way
of life with new medicines, building materials and
technological devices, nanoparticles, the building blocks
of the consumer products made by nanotechnology, can
also display unexpected and unusual forms of toxicity.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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the potential to be toxic in their nanoform [13]. This is
seen with silver which is benign in its bulk form yet is
used as an antibacterial in its nanoform [14]. The uncer-
tainty around nanoparticles is enhanced by gaps in our
ability to identify or determine the presence of nanopar-
ticle toxicity or other possible adverse impacts. Currently
there is a lack of appropriate or standard tests to identify
or characterise many nanoparticles as well as a lack of
toxicological data [13] and population exposure mea-
surements [11,15-18]. To further complicate matters
there is an increasing sophistication of nanotechnology
products as four generations (passive, active, integrated
nanosystems, molecular nanosystems) of products are
released into the public arena [8].
This uncertainty makes an understanding of public
risk perceptions important to policy makers. There is a
high potential for a dissociation between the views of
scientific and technologically informed communities
(including high tech business) and public reactions.
There are many examples in environmental risk history
where a failure to understand or align with public opinion
has fed a public backlash resulting in reactive policy and
regulation and/or an erosion of trust in the government.
These include the Genetically Modified Organism debate
in Europe and the Bovine Spondylitis Encephalopathy crisis
in Britain [19]. Concerns have been raised that insensitivity
to public opinion could cause similar reactions to real or
imagined risks associated with nanotechnology [5,20]. Reg-
ulators and policy makers need to understand how the
public perceives the risks from nanotechnology and how
these perceptions differ from expert opinion. Effective
regulatory decision-making must incorporate an under-
standing of this context of radically differing and some-
times volatile risk perceptions [21].
Our study proposes to extend and develop the know-
ledge base regarding perceptions of risk from nanotech-
nology and trust by stakeholders. To do this we use a
standardised questionnaire across all the stakeholders
surveyed. Secondly we examine stakeholder groups be-
yond highly published scientists and people attending
nano conferences/working in nano laboratories that had
previously been surveyed to include academic, govern-
ment and business stakeholders. These three groups
were chosen not just for their expertise, but because
they represent the interplay of stakeholders most likely
to shape policy in this field. Thirdly we seek and report
on views of general risk perception (to health) and for
specific products (food, cosmetics and sunscreens, medi-
cines, pesticides, tennis racquets and computers) which
broadly represent Australian regulatory arms [22]. Finally we
explore several trust actors (health department, scientists,
journalists and politicians), all of who have the ability to
shape policy.Our study aims to test six hypotheses. First, very little
targeted research has been undertaken on differing
stakeholder views of risks from nanotechnology. To ex-
plore this we hypothesise that public perceptions of risks
from nanotechnology will be greater than those held by
‘experts’. Second, existing studies suggest that food and
health applications of nanotechnology are likely to
arouse more controversy [23]. We will test the hypoth-
esis that the public, academics, government and business
respondents will all perceive a higher level of risk in
nanotechnologies that penetrate or have close and
prolonged contact with the body. Three, there is in-
consistent evidence that increased familiarity with
nanotechnology is associated with differing percep-
tions of nanotechnologies [24]. Our third hypothesis
proposes that public self-reported familiarity with
nanotechnology will be associated with a reduction
in risk perception. This relationship will be found
with each of the nano products in the study. Four,
the public holds less trust in the government agen-
cies with responsibility for regulating nanotechnology
than that expressed by people working in nanotech-
nology based industries/researching nanotechnology
[23]. Our fourth hypothesis tests the evidence for
this proposition. We hypothesise that the trust the
public vests in scientists, the health department, journal-
ists and politicians will be less than those held by busi-
ness, academic, and government respondents who have
an interest in nanotechnology.
The last two hypotheses expand on hypothesis four,
examining the trust of the public in greater detail. Stud-
ies have shown that the Australian public are more likely
to trust scientists and scientific institutions, followed by
government agencies with industry and mass media
holding the least amount of trust [25,26]. In our fifth hy-
pothesis we test the proposition that the public will have
greatest trust in scientists, followed by the health depart-
ment with trust in journalists and politicians below these
two. Finally, public trust in business leaders [27], science
and consumer protection agencies [28] and government
agencies [29] have all been associated with decreased
nano risk perception. Examining other stakeholders, the
greater trust that people working in nanotechnology
based industries or researching nanotechnology had with
scientists and government agencies, the less they per-
ceived risk from nanotechnology [23,30]. Our sixth hy-
pothesis is that significant negative associations exist
between the trust the public vest in scientists, health de-
partment, journalists and politicians and perceived risk
of nanotechnology, both when this risk is considered
to health and across all risk applications. Under-
standing this relationship between trust and risk per-
ception is an important avenue for risk communication
and education.
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Participation details
In March 2013 we undertook a nationally representative
cross-sectional household survey of adult individuals,
who provided verbal consent, using computer assisted
telephone interviewing (CATI) landline (response
rate = 34%) and mobile phone technologies (response
rate = 19%). Sampling was based on random selection
from a stratified area probability sample of private dwell-
ings and mobile phone users. All participants were re-
cruited through random digit dialling sampling. Sample
weights accounted for the probability of selection, cali-
brated by age and gender (but not for jurisdictional strata)
to the June 2012 Australian Bureau of Statistics (ABS)
Estimated Resident Population.
From May - July 2013 we undertook a similar survey
of academic, business and government stakeholders
using CATI landline technology. Academic and business
contacts were identified if they belong to the Australian
Nanotechnology Network members list or named in the
2011 Nanotechnology – Australian Capability Report 4th
edition. Government contacts were identified through
snowballing technique instigated by one of the authors
who is actively involved in the area. A total of 1732 aca-
demic, 69 business and 45 government contacts were
identified. All identified business (response rate = 36%)
and government contacts (response rate = 48%) were
approached while a simple random sample of academic
contacts (response rate = 33%) through random sorting
and selection was undertaken.
Survey design/measures
The survey was developed from previous studies
[25,31-33] and cognitively tested on 10 random individ-
uals of varying ages and gender following Australian
Bureau of Statistics guidelines [34]. Final survey mea-
sures were chosen based on cognitive understanding and
easing of respondent fatigue and subject to expert re-
view. Common survey questions were repeated verbatim
across all surveys and in the same order to ensure com-
parability of answers and order of questions within a
topic were randomised to avoid ordering effects. Partici-
pants were introduced to nanotechnology and manufac-
tured nanomaterials, presented in a neutral fashion to
minimise bias. They were told “Nanotechnology is sci-
ence at a very small scale and refers to a new array of
devices and materials whose key parts are 10 000 times
smaller than the width of a human hair. Working at this
scale allows science researchers to create new materials
and products”, “Manufactured nanomaterials are the mi-
nute particles produced from nanotechnology. They are
found in over 1000 products on the world market today
including some food containers, cosmetics and sun-
screens, clothing, sporting goods and computers”. Theprimary six outcome variables of interest (applications)
for measuring perception of risk was based on the re-
sponse to the questions “Overall, in my opinion, manu-
factured nanomaterials are a risk (to my health) (if they
are put in the food I eat)” or “Overall in my opinion,
putting manufactured nanomaterials into products such
as (cosmetics and sunscreens) (medicines) (pesticides)
(tennis racquets and computers) is a risk.” and were
categorised into agree versus disagree. Respondents were
asked to consider both risks AND benefits when answer-
ing these questions.
Independent variables included basic demographics
(age, gender) and ‘nano trust’ (of the health department,
scientists, journalists and politicians to keep them safe from
possible health effects of manufactured nanomaterials).
The public survey included questions measuring ‘nano
familiarity’, while the academic, business, government
survey included area of speciality.
‘Nano trust’ was determined in response to the ques-
tion “In general how much do you trust X to keep you
safe from any possible health effects of nanomaterials?
Would you say you have no trust at all, a little trust,
moderate trust, a lot of trust or absolute trust?”. The an-
swers were then collapsed into a 3 point ‘low’ (no – a
little), ‘moderate’ (moderate) and ‘high’ (a lot – absolute)
response.
‘Nano familiarity’ was based on a composite of three
questions. “Before today, had you heard of the term
‘Nanotechnology’” (Yes/No), if yes “Have you ever
talked about nanotechnology with anyone before
today?”, “Have you ever searched for information
about nanotechnology?” (Yes, frequently; Yes, occa-
sionally; Yes, only once or twice; No, never). No fa-
miliarity was based on a “no” answer to the first
question, moderate familiarity on a “yes” answer to all
questions, while some familiarity was the composite of
the remaining answers.
The final survey instrument received ethics approval
through the University of Sydney Ethics Committee.
(2012/1841).
Statistics
Data were analysed using SAS Enterprise Guide 6.1 with
the Proc Survey function. The Proc Survey function
allows analysis to be corrected for weighting and
stratified sample design for the public survey data to
provide prevalence estimates. Statistical significance
between all four stakeholders was determined at a p value
of ≤ 0.05 and is reported as such in this paper. For
analysis of public or academic data only a secondary
p value of ≤ 0.01 was also considered to account for
multiple comparisons. The sample size for business
and government respondents were not large enough
to consider the p value of ≤ 0.01.
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holder prevalence estimates of risk perceptions, trust
and familiarity were undertaken by comparing overlap-
ping 95% confidence intervals. Comparisons which
contained non-overlapping confidence intervals were
considered significant.
Analysis of public survey data was undertaken using
descriptive statistics, chi squared analysis and paired test
of proportions.
Public survey data were also analysed by unadjusted
and adjusted logistic regression using the SurveyLogistic
procedure. Two sets of logistic regression models were
developed. The first set, consisting of 6 logistic regres-
sions, examined the relationship between the six percep-
tions of risk and familiarity before and after adjusting for
age and gender. As such it examined the six primary
variable outcomes of interest (defined above) against
nano familiarity, age and gender. The second set, con-
sisting of 24 logistic regressions, examined the relation-
ship between the six perceptions of risk and four trust
actors before and after adjusting for nano familiarity, age
and gender. All variables were retained in adjusted logis-
tic regression models as these variables were central to
the purpose of the study [35]. The Wald test was used
to determine statistical significance and significant ef-
fects are also indicated with odds ratio confidence inter-
vals that do not cross the value of 1.
Results
Demographics/descriptive statistics
The surveys consisted of 1355 public, 301 academic, 19
government and 21 business responses. Gender repre-
sentation of the weighted public survey population was
comparable to the June 2012 Australian population esti-
mates of approximately 50% male and female. Gender
representationa for academic and business responses was
more likely to be male (≈70%) while the gender of
government respondents was almost evenly balanced.
Three hundred and ninety eight public respondents
(30%) were categorised as having no familiarity with
nanotechnology, while 528 (39%) were categorised as
having some familiarity and 422 (31%) as having moder-
ate familiarity with nanotechnology.
Amongst the academic responses, the best represented
area of research (38%) was in the field of nanomaterials.
Nanocharacterisation, nanofabrication, nanobiotechnology/
nanomedicine, nanoscale theory/computation, nanopho-
tonics, and nanoelectronics/nanomagnetics represented
between 15% to 4% per discipline in descending order.
The least represented discipline was translational
nanoresearch (2%), of which half were involved in
nanotoxicology and the other either in ethical or social
research on risk/public attitudes/public impact or did not
provide a sub specialisation. Of the business responsesthe greatest percentage of business involvement was in
nanomaterial manufacture, importation or research
(33% – 23%). Importation of products containing
nanomaterials, waste collection/processing and legal
issues had little representation. The highest representation
of government respondents was health and safety (37%)
followed by communication/social impact (26%), business
development (16%) and environment (11%).
Risk perception
Examining the public perception of risk through chi
squared analysis we found that females were more likely
to consider nanotechnology as a risk for all applications
(p ≤ 0.01) and the elderly were more likely to consider
nanotechnology a risk to their health, or if put in
cosmetics/sunscreen, pesticides and tennis racquets/
computers (p ≤ 0.01). Further details can be found in
the Additional file 1: Table S1 and Additional file 2:
Table S2. Using comparison of confidence intervals we
found that the general public’s perception of risk was
significantly higher than that found in the survey of
academic, government and business opinion. This rela-
tionship was consistent whether risk was considered to
health or for all 5 products (Table 1).
Comparative risk between applications
For public opinion, manufactured nanomaterials put in
food were considered the greatest risk. This was followed
by cosmetics/sunscreens, medicines, pesticides and tennis
racquets/computers. This pattern of proportionate risk
ranking was not consistent across the other stakeholders.
Academic responses identified food, business responses
identified pesticides and government responses identified
cosmetics/sunscreens as the highest risk (Table 2).
Table 2 ranks the percentage of agreement that manu-
factured nanomaterials are a risk to health or if placed
in the 5 chosen products from highest to lowest. Also
within each stakeholder group the percentage of agree-
ment that manufactured nanomaterials are a risk to
health is compared to the percentage of agreement that
manufactured nanomaterials are a risk if placed in each
of the 5 chosen products. The public perceived the
risk of manufactured nanomaterials in food, cosmetics/
sunscreens, medicines as significantly higher and pesti-
cides and tennis racquets/computers as significantly
lower than the risk of manufactured nanomaterials to
health. When adjusting for multiple comparisons, the
significant difference remained for all products with the
exception of pesticides. Significant differences for other
stakeholders can be found in Table 2.
Public familiarity and nanorisk
The results in Table 3 show a dose response effect be-
tween increased public familiarity with nanotechnology
Table 1 Perceptions of risk in different nanotechnology applications across stakeholder groups
Public Academic Government Business
Application Risk n^ % 95% LCI 95% UCI n % 95% LCI 95% UCI n % 95% LCI 95% UCI n % 95% LCI 95% UCI
Health Agree 798 65.7 62.2 69.2 71 26.7 21.4 32.0 4 21.1 2.2 39.9 1 5.0 0.0 14.8
Food Agree 1054 84.8 82.3 87.3 144 55.4 49.3 61.4 6 33.3 10.9 55.8 4 20.0 2.0 38.0
Cosmetics/
sunscreen
Agree 913 72.2 69.0 75.4 107 39.5 33.6 45.3 8 44.4 20.8 68.1 2 10.5 0.0 24.7
Medicines Agree 866 70.8 67.5 74.0 88 32.6 27.0 38.2 3 15.8 0.0 32.6 1 5.0 0.0 14.8
Pesticides Agree 808 63.8 60.3 67.3 106 39.0 33.2 44.8 6 35.3 11.9 58.7 5 23.8 5.1 42.5
Tennis racquets/
computers
Agree 510 39.6 36.1 43.0 20 6.8 3.9 9.7 2 10.5 0.0 24.7 0 0 0 0
^n = number of ‘agreed’ (don’t know/refused removed).
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factured nanomaterials to health and in the 5 chosen
products. The health, food, medicines and tennis
racquet/computer dose response functions were stron-
ger, showing marked changes in all three categories of
familiarity, than those found in the cosmetics/sunscreen
and pesticides functions. Comparing Table 3 and Table 1
shows that even the public who were most familiar with
nanotechnology do not attain the prevalence of reduced
risk perception as those in academia, government or
business, and that the difference in these prevalences are
statistically significant. Increased familiarity was associ-
ated with a significant decrease in the perception of risk
of manufactured nanomaterials to health and for all
products. These associations remained when adjusting
for age and gender and retained their dose response na-
ture (Table 4). In Table 4 a value less than 1 represents a
reduced risk perception, while a value greater than 1
represents an increased risk perception when compared
to those who had no familiarity with nanotechnology.
Perceptions of trust by stakeholders
Using comparison of confidence intervals we found that
the public had significantly lower opinions of trust in
scientists or the health department to keep them safe
from any possible effects of manufactured nanomaterials
than those held by academic or government respondents
(Table 5). There were few differences between stake-
holders in their trust that journalists and politicians
“would keep you safe from any possible effects of manu-
factured nanomaterials”.
Scientists received the most trust, followed by the
health department across public, academic, government
and business respondents. Journalists and politicians
were the least trusted (Table 5).
Relationship between trust and risk for the public
Public perceptions of trust in the health department,
scientists and politicians were significantly associated
with the reported perceptions of risk of manufacturednanomaterials to health/when in each of the five prod-
ucts. Table 6 displays the results for 24 adjusted logistics
regressions which examine the relationship between the
four trust actors and six risk perceptions after adjusting
for familiarity, age and gender. ‘Low’ trust is the refer-
ence category with an odds ratio < 1 representing a re-
duced risk perception and an odds ratio > 1 representing
an increased risk perception when compared to ‘low’
trust. Where a significant relationship existed between
risk and trust (after adjustment), those with the highest
level of trust exhibited a significantly lower perception
of risk than those with the lowest trust level. The signifi-
cant relationships included public trust in scientists and
all perceived risks, public trust in the health department
and all perceived risks with the exception of perceived
risk of manufactured nanomaterials in pesticides, and
public trust in politicians and all perceived risks with the
exception of perceived risk of manufactured nanomater-
ials in food as well as in tennis racquets/computers
(Table 6).
Discussion
Very little targeted research has been undertaken on dif-
fering stakeholder views of risk perception with regard
to nanotechnology. Ho et al. [30] drew from two separ-
ate studies, one looking at public opinion, the other at
the views of highly published scientists in the field of
nanotechnology to compare their perceptions of risks
and benefits. Although both surveys were not identical,
the authors found the public perceived greater risks and
less benefit for nanotechnology than the scientists, and
were less likely to support funding for nanotechnology.
In contrast Scheufele et al. [36] drew on the same two
studies and showed that the scientists expressed more
concerns than the public in the areas of pollution and
new health problems with regard to nanotechnology.
Siegrist et al. [23] undertook a cross sectional survey
using quota sampling for the public and opportunistic
sampling for experts. They found that perception of risk
was significantly higher amongst the public than experts,
Table 2 Risk ranking of nanomaterials in products with comparison to perceived health risk, by stakeholder
Rank Public n^ % 95% LCI 95% UCI Academic n % 95% LCI 95% UCI Government n % 95% LCI 95% UCI Business n % 95% LCI 95% UCI
1 Food** 1054 84.8 82.3 87.3 Food** 144 55.4 49.3 61.4 Cosmetics* 8 44.4 20.8 68.1 Pesticides 5 23.8 5.1 42.5
2 Cosmetics** 913 72.2 69.0 75.4 Cosmetics** 107 39.5 33.6 45.3 Pesticides 6 35.3 11.9 58.7 Food 4 20.0 2.0 38.0
3 Medicines** 866 70.8 67.5 74.0 Pesticides** 106 39.0 33.2 44.8 Food 6 33.3 10.9 55.8 Cosmetics 2 10.5 0.0 24.7
4 Health 798 65.7 62.2 69.2 Medicines 88 32.6 27.0 38.2 Health 4 21.1 2.2 39.9 Medicines 1 5.0 0.0 14.8
5 Pesticides* 808 63.8 60.3 67.3 Health 71 26.7 21.4 32.0 Medicines 3 15.8 0.0 32.6 Health 1 5.0 0.0 14.8
6 Computers** 510 39.6 36.1 43.0 Computers** 20 6.8 3.9 9.7 Computers 2 10.5 0.0 24.7 Computers 0 0 0 0
Note: Within each stakeholder group all 5 products were ranked by order of agreement that manufactured nanomaterials were a risk if found in that particular product. Percentage of each product agreement was
compared to the generic view of risk of manufactured nanomaterials - to health (bolded).
*P value < 0.05 when compared to “health” using paired test of proportions.
**P value < 0.01 when compared to “health” using paired test of proportions.














Table 3 Public risk comparisons by familiarity
No familiarity Some familiarity Moderate familiarity
Application n^ Risk % 95% LCI 95% UCI % 95% LCI 95% UCI % 95% LCI 95% UCI
Health 1177 Agree 80.7 75.3 86.0 63.6 57.6 69.5 54.0 47.9 60.2
Food 1242 Agree 92.1 88.7 95.6 83.9 79.6 88.3 78.8 73.8 83.7
Cosmetics/sunscreen 1234 Agree 84.3 79.8 88.8 68.6 62.9 74.3 65.1 59.3 70.9
Medicines 1211 Agree 85.8 81.5 90.0 67.1 61.5 72.8 60.9 54.9 66.8
Pesticides 1216 Agree 75.0 69.1 80.8 59.5 53.6 65.4 58.2 52.1 64.3
Tennis racquets/computers 1224 Agree 55.6 49.1 62.1 36.1 30.5 41.6 28.8 23.2 34.5
Note - 95% CI used to be consistent with Table 1 as government and business had a small sample size.
^n = number of respondents (don’t know/refused removed).
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Siegrist et al. study was limited by the representativeness
of both public and expert respondents with the public
opinion undertaken via quota sampling and expert via
attendance at a conference or working in a nano-
laboratory. Our study has confirmed and enhanced this
previous research in the area. We confirmed our first
hypothesis that the public’s risk perception of nanotech-
nology is significantly greater than those working in the
area of nanotechnology. This increased perception of
risk is consistent regardless of whether the risk of manu-
factured nanomaterials is considered to oneself or if
placed in one of five representative products.Table 4 Relationship between public familiarity and risk perc
for age and gender
Application (Risk) Familiarity level Unadjusted
Ratio
Health ‘Agree’ No familiarity 1 (Ref)
Some familiarity 0.42
Moderate familiarity 0.28
Food ‘Agree’ No familiarity 1 (Ref)
Some familiarity 0.45
Moderate familiarity 0.32
Cosmetics/sunscreens ‘Agree’ No familiarity 1 (Ref)
Some familiarity 0.41
Moderate familiarity 0.35
Medicines ‘Agree’ No familiarity 1 (Ref)
Some familiarity 0.34
Moderate familiarity 0.26
Pesticides ‘Agree’ No familiarity 1 (Ref)
Some familiarity 0.49
Moderate familiarity 0.47
Tennis racquets/computers ‘Agree’ No familiarity 1 (Ref)
Some familiarity 0.45
Moderate familiarity 0.32Some work has been undertaken on comparative risk
perceptions of specific nanotechnologies, with sugges-
tions that food and health applications are likely to be
more controversial [23]. The Australian public has
shown itself less positive about nanotechnology applica-
tions that affect food and cosmetics than consumer
hardware such as solar panels [25]. Further evidence has
been collected to suggest that those nanotechnology ap-
plications that penetrate into the body are seen as riskier
[28,37,38]. Our second hypothesis proposed that the
public, academics, government and business respondents
will perceive nanotechnologies that penetrate or have
close and prolonged contact with the body as riskier. Oneption (agree versus disagree) unadjusted and adjusted
Odds 99% LCI 99% UCI Adjusted Odds
Ratio
99% LCI 99% UCI
1 (Ref)
0.24 0.74 0.44 0.25 0.78
0.16 0.50 0.30 0.17 0.55
1 (Ref)
0.21 0.95 0.48 0.22 1.0
0.15 0.66 0.36 0.16 0.79
1 (Ref)
0.23 0.72 0.45 0.24 0.80
0.20 0.61 0.40 0.22 0.73
1 (Ref)
0.20 0.60 0.35 0.20 0.63
0.15 0.45 0.27 0.14 0.48
1 (Ref)
0.29 0.83 0.52 0.31 0.92
0.28 0.78 0.52 0.30 0.88
1 (Ref)
0.28 0.72 0.47 0.29 0.77
0.20 0.53 0.35 0.20 0.60
Table 5 Perception of trust in trust actor, by stakeholder group
Public Academic Government Business
Actor Trust n^ % 95% LCI 95% UCI n % 95% LCI 95% UCI n % 95% LCI 95% UCI n % 95% LCI 95% UCI
Health
Department
Low 398 29.1 26.0 32.2 39 13.1 9.3 17.0 2 10.5 0.0 24.7 3 15.0 0.0 31.1
Moderate 644 46.2 42.8 49.6 124 41.8 36.1 47.4 7 36.8 14.5 59.1 9 45.0 22.6 67.4
High 297 24.7 21.7 27.7 134 45.1 39.4 50.8 10 52.6 29.5 75.7 8 40.0 18.0 62.0
Scientists Low 322 23.7 20.8 26.6 28 9.4 6.1 12.8 1 5.3 0.0 15.6 1 5.0 0.0 14.8
Moderate 614 44.3 40.9 47.7 101 34.0 28.6 39.4 4 21.1 2.2 39.9 8 40.0 18.0 62.0
High 400 32.0 28.8 35.2 168 56.6 50.9 62.2 14 73.7 53.3 94.0 11 55.0 32.6 77.4
Journalists Low 778 56.4 53.0 59.8 176 59.9 54.2 65.5 12 66.7 44.2 89.1 7 85.0 68.9 100.0
Moderate 484 37.9 34.6 41.2 96 32.7 27.3 38.0 4 22.2 2.4 42.0 2 10.0 0.0 23.5
High 76 5.7 4.1 7.2 22 7.5 4.5 10.5 2 11.1 0.0 26.1 1 5.0 0.0 14.8
Politicians Low 1019 74.9 71.8 77.9 191 64.7 59.3 70.2 9 47.4 24.3 70.5 18 85.7 70.4 100.0
Moderate 288 22.5 19.6 25.5 89 30.2 24.9 35.4 6 31.6 10.1 53.1 3 14.3 0.0 29.6
High 31 2.6 1.4 3.8 15 5.1 2.6 7.6 4 21.1 2.2 39.9 0 0.0 0.0 0.0
^n = number of respondents (don’t know/refused removed).
Capon et al. BMC Public Health  (2015) 15:424 Page 8 of 13this assumption, food would be seen as riskiest because
of its internalisation in the body and the perception that
manufactured nanomaterials are an unnatural additive
to foodstuffs [5,28]. Previous research has suggested that
cosmetics/sunscreens and medicines are likely to be per-
ceived as the next most risky applications [25]. We
hypothesised that their risk rating is high due to their in-
ternalisation or close prolonged contact with the body,
but they are seen as less risky than food because of their
beneficial to health nature. Pesticides are likely to rank
after cosmetics/sunscreens and medicines because al-
though they may be seen as hazardous, exposure will be
seen as infrequent. Finally computers/tennis racquets
will be seen as the least risky because of their level of
contact with the body, beneficial use and lack of mental
association with a hazardous product.
Our study provides evidence that both the public and
academics discriminate between the risks of nanomater-
ials when used in different applications (Table 2). This
confirms part of our second hypothesis. The survey re-
sults show that the public can differentiate between the
applications of nanotechnology. The mental strategies
required to undertake this differentiation were explored
in our second hypothesis, which suggested that all stake-
holders would rank the relative risks of nanotechnology
higher or lower depending on exposure to the product,
its perceived “naturalness” and its association with previ-
ous human health “disasters”. Although the concept of
exposure appeared strong, with all stakeholders ranking
the relative risk of manufactured nanomaterials in food
or cosmetics/sunscreens as high and computers/tennis
racquets as low, only the public ranked the risks as we
hypothesised (food the highest risk followed by cos-
metics and medicines, pesticides and finally computers).
The main difference lay in the ranking of pesticides ofwhich academic, business and government responders
placed greater relative importance upon than the public
(Table 2). It is difficult to interpret why this is the case.
One scenario is that the relative ‘real’ risk of manufac-
tured nanomaterials in pesticides is greater than what
the public think. Another possibility is that, those work-
ing in the nanotechnology area might be more sensitive
to negative perceptions of pesticides compared to the
other products, or work in an area where pesticides are
their interest (such as pesticide testing and regulation,
especially for business and government responses where
respondent numbers were low).
Examining the prevalence of risk concern, more than
60% of the Australian public agree that manufactured
nanomaterials in products surveyed were a risk, except-
ing only consumer products such as tennis racquets and
computers. Therefore in terms of regulatory importance,
those sectors that are sensitive to public concern include
food, cosmetics/sunscreens, medicines and pesticides. In
Australia, the regulators of these sectors include Food
Standards Australia New Zealand, the National Industrial
Chemicals Notification and Assessment Scheme, the
Therapeutic Goods Administration and the Australian
Pesticides and Veterinary Medicines Authority. Overlay
this with the relative importance other stakeholders place
on the issues, and food and cosmetics/sunscreens are areas
of greatest concern, and therefore could be seen as areas
most likely to create public outrage.
One limitation of these findings comes from changing
public awareness of the nanotechnology debate. The sur-
vey was administered during March 2013 just as a media
debate was started around the potential risks of nanoma-
terials in sunscreens [39]. The ‘pro’ argument was cham-
pioned by the Public Health Association of Australia,
Australian Cancer Council and Australian Commonwealth
Table 6 Association between public perception of trust and risk (agree versus disagree), adjusted for familiarity, age and gender
Health Department Scientists Journalists Politicians
Application (Risk) Trust level Adjusted Odds
Ratio
99% LCI 99% UCI Adjusted Odds
Ratio
99% LCI 99% UCI Adjusted Odds
Ratio
99% LCI 99% UCI Adjusted Odds
Ratio
99% LCI 99% UCI
Health ‘Agree’ Low 1 (Ref)** 1 (Ref)** 1 (Ref) 1 (Ref)**
Moderate 0.68 0.39 1.17 0.67 0.35 1.25 1.04 0.66 1.65 0.85 0.50 1.42
High 0.36 0.20 0.67 0.27 0.14 0.53 0.56 0.24 1.34 0.16 0.04 0.59
Food ‘Agree’ Low 1 (Ref)** 1 (Ref)** 1 (Ref) 1 (Ref)
Moderate 0.71 0.36 1.40 0.80 0.34 1.85 1.20 0.67 2.13 0.83 0.44 1.57
High 0.37 0.18 0.78 0.34 0.14 0.78 0.51 0.18 1.47 0.21 0.05 0.83
Cosmetics/sunscreens
‘Agree’
Low 1 (Ref)** 1 (Ref)** 1 (Ref) 1 (Ref)**
Moderate 0.60 0.34 1.05 0.51 0.25 1.03 1.00 0.63 1.60 0.74 0.44 1.26
High 0.30 0.16 0.56 0.22 0.11 0.44 0.53 0.22 1.28 0.14 0.04 0.47
Medicines ‘Agree’ Low 1 (Ref)** 1 (Ref)** 1 (Ref) 1 (Ref)**
Moderate 0.74 0.44 1.26 0.59 0.31 1.14 1.08 0.68 1.70 0.87 0.51 1.48
High 0.44 0.24 0.80 0.27 0.14 0.53 0.52 0.23 1.18 0.20 0.06 0.61
Pesticides ‘Agree’ Low 1 (Ref) 1 (Ref)** 1 (Ref) 1 (Ref)**
Moderate 0.81 0.49 1.34 0.63 0.35 1.14 1.18 0.76 1.84 1.02 0.61 1.71
High 0.53 0.29 0.96 0.31 0.17 0.6 0.70 0.32 1.56 0.14 0.04 0.50
Tennis racquets/computers
‘Agree’
Low 1 (Ref)** 1 (Ref)** 1 (Ref) 1 (Ref)
Moderate 0.78 0.49 1.25 0.70 0.41 1.15 1.09 0.71 1.68 0.82 0.49 1.36
High 0.33 0.18 0.60 0.28 0.16 0.50 1.05 0.47 2.34 0.28 0.07 1.11
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their support on Australia’s very high rates of melanoma.
In this view, the demonstrable protective effects of sun-
screen easily overcame the (unknown) potential risks
that manufactured nanomaterials in sunscreens may
present [40]. The ‘anti’ argument was championed by
the environmental activist group Friends of the Earth
Australia, who demanded a broader public ‘right to
know’ about the use of nanomaterials. They relied on a
strong version of the precautionary principle to argue
that regulatory approval should be withheld until more
was known about the possible detrimental effects of
nanomaterials issues [41].
A review of the existing quantitative research on nano-
technology perception found inconsistent evidence on
how levels of knowledge and familiarity with nanotech-
nology relates to perceptions [24]. The relationships be-
tween familiarity and perceptions of nanotechnology
have been explored in a number of ways including sur-
veys of support for nanotechnology in food and food
packaging [29], attitudes towards nanotechnology [42],
the support of use and moral acceptability of nanotech-
nology [43] and support for funding of nanotechnology
[44]. Studies examining the interaction between nano-
technology risk perception and knowledge/familiarity
have found increased knowledge/familiarity is signifi-
cantly associated with a reduction in risk perception
[31,45]. These results are based on views of nanotech-
nology as a whole. The value of this very general assess-
ment of risk has been questioned [20], in the face of
evidence that different nanotechnology applications
evoke different perceptions [28,46]. These critics have
advocated the assessment of nanomaterials in a more
product based manner [47,48]. Our third hypothesis
aimed to address these criticisms by examining the rela-
tionship between public familiarity and risk perception
in a more product based manner. We found that in-
creased public familiarity with nanotechnology was sig-
nificantly associated with a reduced perception of risk.
This confirms our third hypothesis. When public famil-
iarity was compared to academic, government and busi-
ness opinions using comparison of confidence intervals
we found that familiarity alone could not explain the
entire difference between public and academic, govern-
ment and business perceptions in most cases (Tables 1
and 4). These results show that even when informed, the
public is unlikely to achieve the same level of reduced
risk perception in nanotechnology as those who have a
professional interest in nanotechnology, a disparity im-
portant to consider in policy making. Further, it would
be premature to assume from these results that increas-
ing public familiarity with nanotechnology for example,
through education, is likely to reduce perceived risks
and the gap between public and academic, business andgovernment perceptions. While familiarity was associ-
ated with a reduction in risk perception, we cannot
rule out the influence cultural factors may have on
these results. It should be noted that some believe
values [20,45] are more important factors to consider.
Another important factor to consider is message fram-
ing with qualitative studies showing, post discussion,
an increase [49] or decrease [38,50] in perceived risk
depending on how the message was framed. However,
it can also not be ruled out that this disparity is in
part induced by measurement bias, that being the
measure of moderate familiarity is classified at a lower
knowledge base than those who have a professional
interest in nanotechnology.
Trust has long been promoted as an important factor
associated with risk perception [51]. Trust reduces the
complexity of decision making (or opinion formation) by
accepting the risk of relying on the judgement of an-
other party [52]. Models of trust include the causal chain
mode of trust, which advocates that the direction of the
association between trust and risk perception is from
trust to risk perception, i.e. levels of trust shape percep-
tions of risk [52,53]. Within the broad trust concept, it
has been argued that pre-existing knowledge, type of risk
and type of trust may all influence the strength of the
trust – risk perception relationship [51,54].
Trust has been shown as a significant factor when it
comes to nanoparticle risk perception [24] and is an im-
portant part of the framing of public policy towards the
use of nanomaterials [5,10,20]. The trust the public have
in government agencies regarding nanotechnology was
found to be lower than that of people working in
nanotechnology based industries and nanotechnology
researchers [23]. Our fourth hypothesis compared per-
ceptions of trust between the public and academic, busi-
ness and government respondents. It suggested that the
trust the public vests in scientists, the health depart-
ment, journalists and politicians will be less than that
held by business, academic, and government officials.
We partially confirmed this hypothesis by finding some
significant differences between public, and academic and
government levels of trust. The public do have less trust
in scientists and the health department to keep them
safe from any potential health effects of manufactured
nanomaterials than those working in nanotechnology in
academia or government.
Studies have shown that the Australian public is more
likely to trust scientists and scientific institutions,
followed by government agencies with industry and mass
media receiving the least amount of trust [25,26]. We
confirmed this in our fifth hypothesis where we found
the public’s overall trust in scientists and the health de-
partment is significantly greater than the trust the public
place in journalists or politicians.
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sumer protection agencies [28] and government agencies
[29] have all been associated with decreased nano risk
perception. We partially confirmed this view in our sixth
hypothesis where we found that those in the public who
have higher levels of trust in scientists, the health de-
partment and politicians to keep them safe from any po-
tential health effects of manufactured nanomaterials
were significantly more likely to perceive lower levels of
risk of manufactured nanomaterials to their health and
for most products. Surprisingly, the levels of trust the
public have in journalists to keep them safe from any
possible health effects of nanomaterials was not associ-
ated with differing perceptions of risk. This result is un-
expected, given the concern expressed over the relatively
large influence the media is likely to have on public
opinion in this area [5,30,55]. It is possible that this mis-
alignment is caused through measurement bias, that is
the public see the role of the journalist as an alarm bell
to alert them (and the government) to the problem,
rather than as a quasi-regulatory function of ‘keeping
them safe’.
The results on levels of trust, hypothesis 4 to hypoth-
esis 6, should alert policy makers to the disparity be-
tween the views of the public and ‘expert’ stakeholders.
If the causal chain mode of trust, where trust affects risk
perception, is applied to these results [52,53], Australian
scientists and health department officials are best placed
to communicate to the public about the risks and bene-
fits of nanomaterials. However policy makers should be
aware that the ‘faith’ the public bestows on scientists and
health department officials may not be as large as the
experts believe (or hope).
Our study contained a number of strengths. Unlike
other peer reviewed publications in this area it sought
opinions from a number of ‘expert’ stakeholders who are
most likely to shape policy in this field. We provided a
neutral definition of nanotechnology and nanomaterials.
Given the potential influence framing may have on the
perception of this issue, we ensured neither definition
suggested benefits or risks. The concept of risk was pre-
sented in a holistic context. Respondents were asked to
consider both the risks and benefits when providing a
level of risk, with the Likert response scale ranging from
minus two (agree strongly) to plus two (disagree
strongly) to try to capture this balance. This decision
was made after cognitive testing revealed that if the risk
question was reversed, using the word ‘benefit’ rather
than ‘risk’, the respondents perceived this ‘benefit’ ques-
tion as the exact opposite of the ‘risk’ question. Risk and
benefit has been justified as an inverse relationship [56],
and asking about risk in this manner has been under-
taken elsewhere [45,46]. Finally questions within topics
were randomised and all questions that were comparedacross stakeholders were repeated verbatim to ensure
comparability.
Our study has a number of limitations. Measurement
bias may have been introduced if those who responded to
our study were statistically different from those who de-
clined to participate. In an anonymous CATI survey it is
not possible to contact those who refused to participate to
determine this bias. Information on academic, government
and business contacts in the area of nanotechnology are
difficult to acquire and all reasonable attempts were under-
taken to ensure these were complete. However it is pos-
sible that our sample frame for academic, business and
government did not include all those involved in the aca-
demic, business and government nanotechnology area in
Australia. Also, the small number of respondents for busi-
ness and government provided little power to determine
associations. The response rate was similar or higher than
for other groups, the sample size was an artefact of the
small number of people employed in these categories. Fi-
nally, given the number of comparisons undertaken in our
analysis a significance value of 0.05 meant a high probabil-
ity of a type 1 error (obtaining significance by chance).
Where the sample size allowed (public and academic) we
also considered a significance level of 0.01. While the risk
of a type 1 error was likely, many of our comparisons (and
conclusions) were made across a range stakeholders
or applications, with statistical significance consistent
across these multiple analyses, giving us greater confidence
that the effect we were detecting was real.
Conclusion
The Australian public perceives greater risks from man-
ufactured nanomaterials and shows less trust in scien-
tists and the health department to provide protection
from possible health effects than academic, business and
government stakeholders in the nanotechnology sector.
Food applications and cosmetics/sunscreens loom high on
the list of public concerns, although medicines and pesticides
are also causes of public concern. Policy makers should be
aware of these risk and trust disparities and address public
sentiment by treating nanotechnology applications in the
higher risk areas with greater caution. Risk communication
is best placed in the hands of trusted scientists.
Endnote
aNot all gender data was collected for all academic,
business and government participants.
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